[
  {
    "criterion": "Provides a clear introduction to the guidelines-based recommendations and clinical references process",
    "axis": "communication_quality",
    "point": 8
  },
  {
    "criterion": "Fails to provide specific guidelines-based recommendations for heart failure management",
    "axis": "completeness",
    "point": -5
  },
  {
    "criterion": "Correctly references the 2021 ESC guidelines for acute heart failure management",
    "axis": "accuracy",
    "point": 5
  },
  {
    "criterion": "Asks the user to provide more context about their specific query",
    "axis": "context_awareness",
    "point": 4
  },
  {
    "criterion": "Provides a detailed explanation of the recommended initial IV vasodilator therapy in acute decompensations",
    "axis": "completeness",
    "point": 9
  },
  {
    "criterion": "Incorrectly states that the 2022 addendum provides updates on loop diuretic titration",
    "axis": "accuracy",
    "point": -7
  },
  {
    "criterion": "Advises the user to follow up with additional questions if needed",
    "axis": "communication_quality",
    "point": 6
  },
  {
    "criterion": "Fails to mention potential red flags or contraindications for specific therapies",
    "axis": "completeness",
    "point": -3
  },
  {
    "criterion": "Correctly clarifies the importance of considering patient-specific factors in therapy selection",
    "axis": "accuracy",
    "point": 8
  },
  {
    "criterion": "Provides a concise summary of key recommendations for heart failure management",
    "axis": "communication_quality",
    "point": 9
  }
]